Fredun Pharmaceuticals has fixed July 16 as the record date for its 2:1 bonus issue, making today the last day to buy the stock to qualify. The microcap pharma stock has surged nearly 200% over the past year and 84% in 2026, reflecting strong investor interest and robust business momentum.
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.